Menu

First Human Case of H7N4 Bird Flu Confirmed

The woman, a resident of southeast China, has since recovered.

Feb 15, 2018
Shawna Williams

ISTOCK, BLUEBERRIESA 68-year-old woman in Jiangsu Province, China, was admitted to a hospital on January 1 with what turned out to be a H7N4 bird flu virus infection, Hong Kong’s Centre for Health Protection announced yesterday (February 14). The patient, who had contact with live poultry before her symptoms started, is believed to be the first person infected by the H7N4 virus. She later recovered and was discharged.

According to the World Health Organization, influenza type A viruses (of which H7N4 is one type) are of public health concern because they have the potential to cause pandemics if they acquire the ability to be transmitted among humans. A different bird flu strain, H7N9, has killed at least 600 people in China since 2013, Reuters reports.

Hong Kong has reported 21 cases of H7N9 in humans, all traced to mainland China, the South China Morning Post reports. The warning from the territory’s health department, which comes at the start of Chinese New Year, urges visitors to the mainland to avoid contact with live or freshly-killed poultry.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.